Please assess the completion status of the following clinical trial:

Trial Title: Pregnancy Outcomes and Maternal Insulin Sensitivity

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy singleton pregnant women (10-12 weeks of gestation)~* BMI ≥25 kg/m2~* FPG ≤7.0 mmol/l~* Dutch or English speaking~* Written informed consent~Exclusion Criteria:~* Serious health complications (Hypertension, Hyperlipidemia, Asthma, Haemochromatosis) or medication use that influence the glucose metabolism or fetal growth (e.g. corticosteroids).~* Multiple pregnancy~* pre-existing Diabetes type 1 and 2 defined as FPG ≥7.0 mmol/l or use of diabetes medication~* Participation in any other studies involving the investigation of medication or nutritional products or severe illness or antibiotic use in the two weeks prior to entry into the study~* HIV/Hepatitis~* Expectation of non-compliance to the study protocol, among others, a fear of needles~* Known allergies or intolerances for one or more nutritional ingredients in the MTT~* Psychological dysfunctions

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: None

Study Arms:
- Healthy women pregnant of singleton with a BMI ≥25 kg/m2 (Type: None): Healthy women pregnant of singleton with a BMI ≥25 kg/m2 will be followed from 12 weeks of gestation till 6 months postpartum. Neonates will be followed from birth up to 6 months of age.

Based on this trial design, predict the completion outcome and termination type (if applicable).